Predictors of fracture in middle-aged and older adults with type 2 diabetes and overweight or obesity.

Rachel E ElamKaren C JohnsonHongyan XuCarlos M IsalesYanbin DongLaura D Carbone

Published in: The Journal of clinical endocrinology and metabolism (2024)

Thiazolidinedione and insulin use predict clinical fracture in middle-aged and older persons with type 2 diabetes and overweight or obesity. Evaluating BMD is advisable if these medications are prescribed. Fracture risk prediction tools may consider including thiazolidinedione and insulin use to refine prediction in this population.

Keyphrases

weight loss
type diabetes
weight gain
physical activity
insulin resistance
glycemic control
metabolic syndrome
hip fracture
high fat diet induced
body mass index
middle aged
community dwelling
skeletal muscle